Anthracycline antibiotic blockade of SV40 T antigen helicase action

被引:14
作者
Bachur, NR
Lun, L
Sun, PM
Trubey, CM
Elliott, EE
Egorin, MJ
Malkas, L
Hickey, R
机构
[1] Univ Maryland, Sch Med, Ctr Canc, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Pharm, Ctr Canc, Baltimore, MD 21201 USA
关键词
anthracyclines; daunorubicin; doxorubicin; T antigen; DNA helicase;
D O I
10.1016/S0006-2952(97)00617-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We previously showed that anthracycline antibiotics potently block SV40 large T antigen helicase; in the present study, we describe the kinetics and the structure-activity characteristics of this process. The concentration vs effect data for helicase blockade were fitted by the Hill equation to yield nearly parallel log-concentration effect curves for a series of active anthracycline antibiotics. The effective concentration for 50% helicase blockade (EC50) values ranged from 0.34 mu M for daunorubicin to 40.8 mu M for 3'-deaminodaunorubicin. Clinically inactive 3'-N-acyl anthracyclines produced no blockade. The Hill constants for the blockade ranged from 1.1 to 1.6 for the entire series of active anthracyclines, indicating no positive cooperativity and suggesting that a single molecule of bound drug is sufficient to block helicase action. The EC50 values for several clinically effective anthracyclines showed a relationship to the average DNA binding constants for these drugs, and Lineweaver-Burk analysis of the blockade kinetics indicated non-competitive inhibition. The kinetics of the blockade indicated that the anthracycline, DNA, and helicase form a ternary complex that is irreversible under the reaction conditions. This mechanism may be central to the cytotoxic and anti-cancer activities of anthracycline antibiotics and may be useful in understanding the enzymatic mechanism of DNA helicase action. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:1025 / 1034
页数:10
相关论文
共 43 条
[1]  
AZALOS A, 1979, BIOCHEM PHARMACOL, V28, P335
[2]  
BACHUR NR, 1992, MOL PHARMACOL, V41, P993
[3]  
BACHUR NR, 1977, MOL PHARMACOL, V13, P901
[4]  
BACHUR NR, 1993, MOL PHARMACOL, V44, P1064
[5]  
BACHUR NR, 1995, ACS SYM SER, V5714, P204
[6]  
BODLEY A, 1989, CANCER RES, V49, P5969
[7]  
CAPRANICO G, 1986, CANCER RES, V46, P5499
[8]   PREFERENTIAL BINDING OF DAUNOMYCIN TO 5'ATCG AND 5'ATGC SEQUENCES REVEALED BY FOOTPRINTING TITRATION EXPERIMENTS [J].
CHAIRES, JB ;
HERRERA, JE ;
WARING, MJ .
BIOCHEMISTRY, 1990, 29 (26) :6145-6153
[9]   DISSECTION OF THE FREE-ENERGY OF ANTHRACYCLINE ANTIBIOTIC BINDING TO DNA - ELECTROSTATIC CONTRIBUTIONS [J].
CHAIRES, JB ;
PRIEBE, W ;
GRAVES, DE ;
BURKE, TG .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1993, 115 (13) :5360-5364
[10]   CORRELATION BETWEEN ANTHRACYCLINE STRUCTURE AND HUMAN DNA-LIGASE INHIBITION [J].
CIARROCCHI, G ;
LESTINGI, M ;
FONTANA, M ;
SPADARI, S ;
MONTECUCCO, A .
BIOCHEMICAL JOURNAL, 1991, 279 :141-146